Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 4/20 | 0.41 |
| ▸ | LOX | P28300 | 2/20 | 0.40 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.36 |
| ▸ | PREP | P48147 | 4/20 | 0.34 |
| ▸ | IDO1 | P14902 | 2/20 | 0.34 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.31 |
| ▸ | KDM5A | P29375 | 1/20 | 0.31 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19583845 | 0.83 | P2RX7 (0.34) | LOXL2PREPIDO1P2RX7NOTUM | |
| SCHEMBL3080095 | 0.81 | P2RX7 (0.36) | PREPIDO1P2RX7NOTUM | |
| SCHEMBL21120953 | 0.81 | P2RX7 (0.35) | PREPP2RX7 | |
| Hydrochloric Acid SCHEMBL19583921 | 0.81 | P2RX7 (0.33) | LOXL2LOXPREPIDO1P2RX7 | |
| SCHEMBL20088854 | 0.75 | NOS2 (0.39) | LOXL2P2RX7NOS3NOS2PIK3CD | |
| SCHEMBL31097846 | 0.75 | NOS2 (0.39) | LOXL2P2RX7NOS3NOS2PIK3CD | |
| SCHEMBL6348523 | 0.74 | LOXL2 (0.42) | LOXL2LOXLOXL3 | |
| SCHEMBL364870 | 0.74 | P2RX7 (0.36) | P2RX7NOS3NOS2PIK3CDNOTUM | |
| SCHEMBL2301406 | 0.73 | CXCR4 (0.45) | LOXL2LOXIDO1 | |
| SCHEMBL27333817 | 0.73 | LOXL2 (0.37) | LOXL2LOX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4554931-A1 | PROCESS FOR PREPARING SUBSTITUTED BENZAMIDES | ADAMA MAKHTESHIM LTD. (IL) | 2025-05-21 | — | — | EP | disclosed |
| WO-2024013736-A1 | PROCESS FOR PREPARING SUBSTITUTED BENZAMIDES | ADAMA MAKHTESHIM LTD. (IL) | 2024-01-18 | — | — | WO | disclosed |
| US-20060004206-A1 | Novel process for the preparation of 2-aminomethylpyridine derivative | BAYER CROPSCIENCE S.A. (FR) | 2006-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060004206-A1 | Novel process for the preparation of 2-aminomethylpyridine derivative | AZI2, IL4I1, ABL2 | LOXL2 3033/4885LOX 1682/4885LOXL3 4207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.